Enhabit, Inc. (NYSE:EHAB) Shares Sold by Point72 Asia Singapore Pte. Ltd.

Point72 Asia Singapore Pte. Ltd. reduced its stake in shares of Enhabit, Inc. (NYSE:EHABFree Report) by 49.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,024 shares of the company’s stock after selling 34,385 shares during the period. Point72 Asia Singapore Pte. Ltd. owned about 0.07% of Enhabit worth $274,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of EHAB. 8 Knots Management LLC boosted its holdings in shares of Enhabit by 16.4% during the fourth quarter. 8 Knots Management LLC now owns 4,430,898 shares of the company’s stock valued at $34,605,000 after acquiring an additional 623,602 shares during the period. D. E. Shaw & Co. Inc. raised its holdings in shares of Enhabit by 33.2% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 1,004,215 shares of the company’s stock worth $7,843,000 after purchasing an additional 250,215 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Enhabit by 12.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,953,941 shares of the company’s stock valued at $15,260,000 after acquiring an additional 213,774 shares during the period. Paradice Investment Management LLC raised its holdings in shares of Enhabit by 12.8% during the fourth quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company’s stock valued at $13,903,000 after acquiring an additional 201,997 shares during the period. Finally, Nuveen Asset Management LLC raised its holdings in shares of Enhabit by 95.5% during the fourth quarter. Nuveen Asset Management LLC now owns 265,361 shares of the company’s stock valued at $2,072,000 after acquiring an additional 129,610 shares during the period.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reiterated a “buy” rating on shares of Enhabit in a research note on Thursday, March 6th.

Read Our Latest Analysis on EHAB

Enhabit Price Performance

Shares of EHAB stock opened at $10.76 on Friday. The stock’s fifty day moving average is $8.49 and its 200-day moving average is $8.17. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The stock has a market capitalization of $544.85 million, a PE ratio of -4.64 and a beta of 1.61. Enhabit, Inc. has a 52 week low of $6.85 and a 52 week high of $10.79.

Enhabit (NYSE:EHABGet Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.03. The firm had revenue of $259.90 million for the quarter, compared to analyst estimates of $266.11 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. Equities research analysts expect that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Enhabit Profile

(Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

See Also

Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHABFree Report).

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.